Search Results - "Agreda, Gladys P"
-
1
Adjusted Chemotherapy According to Frailty Status in Elderly Patients With Diffuse Large B-Cell Lymphoma: Experience From a Single Referral Center in Mexico City
Published in Clinical lymphoma, myeloma and leukemia (01-02-2019)“…Chemotherapy is associated with significant toxicity in elderly patients treated for hematological malignancies. Adequate tools to identify the best tailored…”
Get full text
Journal Article -
2
Effectiveness of L-asparaginase-based regimens compared to anthracycline-based regimens in newly diagnosed extranodal NK/T-cell lymphoma, nasal type: a single Mexican center experience
Published in Blood research (01-09-2018)“…Extranodal NK/T-cell lymphoma, nasal type (ENKTCL) has a high prevalence in Asia and Latin American countries, such as Mexico, where it encompasses 40% of all…”
Get full text
Journal Article -
3
Starch and albumin mixture as replacement fluid in therapeutic plasma exchange is safe and effective
Published in Journal of clinical apheresis (2008)“…Therapeutic plasma exchange (TPE) is an effective treatment in Myasthenia gravis (MG) and Guillain‐Barré syndrome (GBS) and 5% human albumin is the replacement…”
Get full text
Journal Article -
4
Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study
Published in Journal of global oncology (01-11-2019)“…Limited information is available on multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma (NHL) management in Latin America. The…”
Get full text
Journal Article -
5
Improvement Diagnosis and Treatment of Mantle Cell Lymphoma in a Middle-Income Country: A Time-Dependent Analysis in Mexico
Published in Blood (23-11-2021)“…Introduction: Mantle cell lymphoma (MCL) is a non-Hodgkin lymphoma representing 4-9% of all lymphomas. The disease prognosis remains adverse. However,…”
Get full text
Journal Article -
6
-
7
National guidelines of diagnosis and treatment of the non-Hodgkin lymphoma
Published in Revista de investigacion clinica (01-06-2013)“…Non-Hodgkin lymphoma comprises a heterogeneous group of haematological malignancies, classified according to their clinic, anatomic-pathological features and,…”
Get full text
Journal Article -
8
Prognosis in Patients with Human Immunodeficiency Virus Infection and Advanced Clinical Stage Classic Hodgkin's Lymphoma
Published in Blood (13-11-2019)“…Classic Hodgkin's lymphoma (cHL) represents 95% of all Hodgkin lymphomas, and is responsible of 0.5% of all cancer types (Siegel, Miller & Jemal, 2016). In HIV…”
Get full text
Journal Article -
9
Proposal of a Novel Latin American International Prognostic Index (LATAM-IPI) for Diffuse Large B-Cell Lymphoma (DLBCL) By the Grupo Para El Estudio De Linfoproliferativos En Latino-America (GELL)
Published in Blood (05-11-2020)“…Introduction. There are different scoring systems to differentiate risk groups in patients with DLBCL treated with chemoimmunotherapy. Those systems have used…”
Get full text
Journal Article -
10
Clinical, Pathological, and Prognostic Characteristics Of Mature Nodal Or Extranodal T-Cell and NK-Cell Non-Hodgkin´s Lymphoma (NHL) In a Single Mexican Institution
Published in Blood (15-11-2013)“…Mature nodal or extranodal T-cell and NK-cell NHL are a rare and heterogeneous group of NHL with aggressive behavior and poor clinical outcome. Their incidence…”
Get full text
Journal Article